ArticleESMO open2021

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program.

V Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.